optorhythm
General Data
Reg Number
517031597
Sector
Medical Devices
Established
2024
No. of Employees
5
Stage
R&D
Additional Funding
1
Description
OptoRhythm – A Breakthrough in Atrial Fibrillation Treatment
Technology
OptoRhythm's technology combines optogenetic gene therapy with an implantable micro-LED array to create an optic defibrillator. It painlessly stops chaotic atrial contractions, using precise light pulses.
Targeted Customers
AF treatment market, physicians.
Management personnel
Yaki Eidelstein - CEO & Co-Founder
Winning details
Route name
Winning year
Technological Incubators 2020
Technological Incubators 2020
2024